Sandoz Group AG Sponsored ADR (SDZNY)
(Delayed Data from OTC)
$55.80 USD
-0.98 (-1.72%)
Updated Aug 6, 2025 10:32 AM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Sandoz Group AG Sponsored ADR has a market cap of $24.98B, which represents its share price of $56.78 multiplied by its outstanding shares number of 440.00M. As a large-cap company, SDZNY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SDZNY 55.80 -0.98(-1.72%)
Will SDZNY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SDZNY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SDZNY
Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Viatris
3 Generic Drug Stocks to Watch Amid Pricing Pressure & Tariff Threats
SDZNY: What are Zacks experts saying now?
Zacks Private Portfolio Services
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals
3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes
Other News for SDZNY
Bayer Stock Is Soaring Ahead Of Its Earnings Release
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics ...
Sandoz to acquire Just-Evotec Biologics from Evotec for $300M
Novartis fails in bid to block MSN Pharma’s generic Entresto as court denies injunction
Sandoz issues recall for additional lot of Cefazolin for injection